Newsroom

Press Releases Events
BioSpace - Boehringer Expands BiomX IBD Biomarker Collab, Shutters Crohn's Trial
Independent - Viruses that help: Is bacteriophage therapy the future of medicine?
Cystic Fibrosis News Today - CFF Supporting Phase 1/2 Trial of Phage Therapy for P. aeruginosa Infections
Phase 2 Trial of BX004, Phage Therapy for Bacterial Infections, Advancing
Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit
Fierce Pharma - BiomX hails clinical data as first for oral phage delivery
IDB News Today - Phage Therapy BX002 Shows Promise in First-in-human Trial
Solebury Trout Talks - Jonathan Solomon, BiomX - Part of the Nametag Series
BiomX Reports Third Quarter 2020 Financial Results and Announces Expanded Portfolio of Phage Therapy Candidates
BiomX Presents Preclinical Results of Phage Targeting Klebsiella pneumoniae for Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
Jefferies 2020 Virtual London Healthcare Conference

Sign up for the latest updates

Join our mailing list to receive company updates
delivered to your inbox Join the list

Reach Us

22 Einstein St., Floor 4
Ness Ziona 7414003
Israel

 +972-72-3942377